CHI3L1 and glioblastoma: A mouse monoclonal anti-YKL-40 antibody (mAY) abolished YKL-40-induced activation of VEGF receptor 2 (Flk-1/KDR) and MAP-mediated intracellular signaling, and abrogated angiogenesis induced by YKL-40 conditioned medium of the glioblastoma cell line U87 with elevated levels of YKL-40 induced by γ-irradiation.